Literature DB >> 32475168

COVID-19: Considerations of Diabetes and Cardiovascular Disease Management.

Antonio Ceriello1, Oliver Schnell2.   

Abstract

Entities:  

Keywords:  COVID-19; SARS -CoV-2; continuous glucose monitoring; diabetes; glucose variability; intensive care unit; telemedicine

Mesh：

Substances：

Year:  2020        PMID： 32475168      PMCID： PMC7673148          DOI： 10.1177/1932296820930025

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN： 1932-2968


× No keyword cloud information.
  13 in total

Review 1.  Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases.

Authors:  Francesco Prattichizzo; Lucia La Sala; Lars Rydén; Nikolaus Marx; Marc Ferrini; Paul Valensi; Antonio Ceriello
Journal:  Eur J Prev Cardiol       Date:  2019-12       Impact factor: 7.804

Review 2.  Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

3.  Glucose Variability and Diabetic Complications: Is It Time to Treat?

Authors:  Antonio Ceriello
Journal:  Diabetes Care       Date:  2020-06       Impact factor: 19.112

4.  COVID-19 and diabetes management: What should be considered?

Authors:  Antonio Ceriello; Anca Pantea Stoian; Manfredi Rizzo
Journal:  Diabetes Res Clin Pract       Date:  2020-04-17       Impact factor: 5.602

5.  Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis.

Authors:  Wen-Cheng Chao; Chien-Hua Tseng; Chieh-Liang Wu; Sou-Jen Shih; Chi-Yuan Yi; Ming-Cheng Chan
Journal:  Ann Intensive Care       Date:  2020-02-07       Impact factor: 6.925

6.  Clinical Characteristics of Coronavirus Disease 2019 in China.

Authors:  Wei-Jie Guan; Zheng-Yi Ni; Yu Hu; Wen-Hua Liang; Chun-Quan Ou; Jian-Xing He; Lei Liu; Hong Shan; Chun-Liang Lei; David S C Hui; Bin Du; Lan-Juan Li; Guang Zeng; Kwok-Yung Yuen; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Ping-Yan Chen; Jie Xiang; Shi-Yue Li; Jin-Lin Wang; Zi-Jing Liang; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Nan-Shan Zhong
Journal:  N Engl J Med       Date:  2020-02-28       Impact factor: 91.245

7.  Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed.

Authors:  Aihong Wang; Weibo Zhao; Zhangrong Xu; Jianwen Gu
Journal:  Diabetes Res Clin Pract       Date:  2020-03-13       Impact factor: 5.602

8.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2020-03-28       Impact factor: 17.440

9.  COVID-19, diabetes mellitus and ACE2: The conundrum.

Authors:  Rimesh Pal; Anil Bhansali
Journal:  Diabetes Res Clin Pract       Date:  2020-03-29       Impact factor: 5.602

10.  Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China.

Authors:  Jun Zhou; Jie Tan
Journal:  Metabolism       Date:  2020-03-24       Impact factor: 8.694
View more
  3 in total

Review 1.  COVID-19 in Latin America and the caribbean region: Symptoms and morbidities in the epidemiology of infection.

Authors:  Julio Y Anaya-Covarrubias; Antonio Pizuorno; Santiago Mirazo; Jesus Torres-Flores; Gisela Du Pont; Edmundo Lamoyi; Nora A Fierro
Journal:  Curr Opin Pharmacol       Date:  2022-02-11       Impact factor: 4.768

Review 2.  The Effects of the Health System Response to the COVID-19 Pandemic on Chronic Disease Management: A Narrative Review.

Authors:  Tetyana Kendzerska; David T Zhu; Andrea S Gershon; Jodi D Edwards; Cayden Peixoto; Rebecca Robillard; Claire E Kendall
Journal:  Risk Manag Healthc Policy       Date:  2021-02-15

Review 3.  Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms.

Authors:  Celestino Sardu; Raffaele Marfella; Francesco Prattichizzo; Rosalba La Grotta; Giuseppe Paolisso; Antonio Ceriello
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.